Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Published Date: 13 Jul 2025

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

4.

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

5.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot